Delta Apparel Incorporated - symbol DLA - reported Another Year of Record Results on its Fiscal 2011, posting net sales of $475.2 million, increased 12.0% compared to the prior year. American Software Incorporated - symbol AMSWA - reported Preliminary First Quarter of its Fiscal 2012 Results. License Fee Revenues increased 139% and GAAP Net Earnings Increased 67% for the quarter, posting Total revenues of $23.7 million, a 24% increase year over year. Sagent Pharmaceuticals Incorporated - symbol SGNT - has received approval from the US Food and Drug Administration for its Orphenadrine Citrate Injection, USP, a skeletal muscle relaxant. According to 2011 IMS data, the U.S. injectable market for orphenadrine approximated $4.3 million. The company expects to launch orphenadrine in the third quarter of 2011.
